Month: September 2021

DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) Stakes Claim as New Kid on CaaS Block

Written by Customer Service on September 17, 2021. Posted in Public Companies.

NEW YORK, Sept. 17, 2021 (GLOBE NEWSWIRE) — NetworkNewsAudio – DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) announces the availability of a broadcast titled, “Digital Media — The Next Generation: AI, Social for Video and Content to Web Ad Commerce.” To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast To view the full editorial, please visit: https://nnw.fm/06a2V As the new kid on the block, DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) is the unsung public company that is making a name for itself with an A-list client roster through Hashoff, a turnkey enterprise level self-service CaaS (Content-as-a-Service) provider built on proprietary AI/ML technology. DGTL planted its flag in the market in January 2020 when it acquired Hashoff for just two times annual revenue at C$4.5 million in cash and stock...

Positive Results Presented at ESMO 2021 From Randomized, Controlled, Phase 2 Trial of Relacorilant in Patients with Recurrent Platinum-Resistant Ovarian Cancer

Written by Customer Service on September 17, 2021. Posted in Public Companies.

Data from Corcept’s 178-patient, randomized, controlled, Phase 2 trial featured in a proffered paper oral presentation at ESMO 2021 Results show statistically significant and clinically relevant benefit experienced by women with recurrent platinum-resistant ovarian cancer who were treated with nab-paclitaxel plus Corcept’s proprietary selective cortisol modulator, relacorilantMENLO PARK, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced that results from its 178-patient, randomized, controlled, Phase 2 trial of relacorilant plus nab-paclitaxel in patients with recurrent platinum-resistant ovarian...

MasterCraft Boat Holdings, Inc. Updates Guidance for Fiscal First Quarter 2022

Written by Customer Service on September 17, 2021. Posted in Earnings Releases And Operating Results.

Reaffirms Full Year Fiscal 2022 Guidance VONORE, Tenn., Sept. 17, 2021 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) (the “Company”) today announced that it is revising its guidance for fiscal first quarter 2022 due principally to a temporary delay in the shipment of a key component from a single engine parts supplier for the Company’s MasterCraft brand. The timing of delivery of these delayed units will shift into the fiscal second quarter 2022. MasterCraft now expects fiscal first quarter 2022 consolidated net sales growth to be up approaching the 30 percent range, compared to the prior estimate of up in the mid-30 percent range; Adjusted EBITDA margins to be in the mid-11 percent range, compared to the prior estimate in the low-14 percent range; and Adjusted Earnings per share for the first quarter to decrease...

Westport Fuel Systems Restates Second Quarter 2021 Financial Statements due to Accounting Error

Written by Customer Service on September 17, 2021. Posted in Earnings Releases And Operating Results.

No impact on gross margin, net income, or the Company’s statement of cash flows.VANCOUVER, British Columbia, Sept. 17, 2021 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“WFS” or the “Company“) (TSX:WPRT / Nasdaq:WPRT) announced that it has filed amended and restated unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2021 (the “Amended Statements“) and related amended and restated management’s discussion and analysis. The Amended Statements were required to correct an accounting error which was identified during an internal review of one of the Company’s subsidiaries’ statutory financial records. All figures are expressed in millions of United States dollars. The Company recently became aware of and corrected a...

Biophytis Reports H1 2021 Financial Results and Provides Business Update

Written by Customer Service on September 17, 2021. Posted in Earnings Releases And Operating Results.

SARA-INT: Positive top line results of Phase 2 study demonstrate efficacy of Sarconeos (BIO101) in sarcopenia and support progress into Phase 3 COVA: DMC second interim analysis shows efficacy results in the promising zone allowing continuation of the phase 2/3 study with Sarconeos (BIO101) in COVID-19. Top line results of the full study are expected in Q1 2022 Manufacturing scale up signed with a major global CDMO to increase potential supply of Sarconeos (BIO10) in anticipation of COVA positive results Biophytis leadership team reinforced with new senior appointments Cash on hand increased to €23 million as of June 30th 2021, compared to €18.8 million as of December 31 2020, following successful IPO on Nasdaq in February 2021. In addition, new convertible bond financing of €32 million signed with AtlasPARIS and CAMBRIDGE, Mass., Sept....

Simply Better Brands Corp. Closes the Acquisition of the Crisp Group

Written by Customer Service on September 17, 2021. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, Sept. 17, 2021 (GLOBE NEWSWIRE) — Simply Better Brands Corp‎. (the “Company” or “Simply Better Brands”) (TSX Venture: SBBC), is pleased to announce that, further to a news release issued on August 19, 2021, the Company has closed its acquisition of Crisp Management Group Inc. (“Crisp”), to focus on the sale and distribution of CBD and Hemp products through an array of Breakaway ‎Music Festivals in throughout North America as well as through Crisp’s e-commerce ‎platform‎. Crisp sells and distributes CBD and hemp products through its e-commerce platform, and also holds the exclusive rights to market CBD and hemp products at Breakaway Music Festivals throughout North America. “On our plant-based wellness mission, we relentlessly focus on efficacy, innovation and brand availability. Our partnership...

Progressive Reports August 2021 Results

Written by Customer Service on September 17, 2021. Posted in Earnings Releases And Operating Results.

MAYFIELD VILLAGE, OHIO, Sept. 17, 2021 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for August 2021: August(millions, except per share amounts and ratios; unaudited)2021 2020 Change Net premiums written $ 3,890.9 $ 3,437.7 13 %Net premiums earned $ 3,513.8 $ 3,088.9 14 %Net income (loss) $ (6.6 ) $ 487.4 (101 ) %Per share available to common shareholders $ (0.02 ) $ 0.83 (102 ) %Total pretax net realized gains (losses) on securities $ 131.5 $ 330.9 (60 ) %Combined ratio 105.3 92.6 12.7 pts.Average equivalent common shares 584.8 587.7 0 % August(thousands; unaudited) 2021 2020 ChangePolicies in Force Personal Lines Agency – auto 8,013.3 7,487.0 7...

Dividend 15 Split Corp. Completes Overnight Offering of $100,100,000

Written by Customer Service on September 17, 2021. Posted in Public Companies.

A high quality portfolio consisting of 15 dividend yielding Canadian Companies TORONTO, Sept. 17, 2021 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. (the “Company”) is pleased to announce it has completed the overnight offering of Preferred Shares and Class A Shares of the Company. Total gross proceeds of the offering were $100.1 million, bringing the Company’s net assets to approximately $1.5 billion. The shares will begin trading on the Toronto Stock Exchange under the existing symbols of DFN.PR.A (Preferred Shares) and DFN (Class A Shares). The Preferred Shares were offered at a price of $10.05 per Preferred Share to yield 5.5% and the Class A Shares were offered at a price of $8.15 per Class A Share to yield 14.7%. The offering was led by National Bank Financial Inc. The net proceeds of the offering will be used by the Company...

Gain Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Written by Customer Service on September 17, 2021. Posted in Public Companies.

– Conference Dates: September 20th-23rd – BETHESDA, Md., Sept. 17, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and optimizing allosteric binding sites never before targeted in neurodegenerative diseases and lysosomal storage disorders, today announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit and invites investors to participate via webcast and in one-on-one meetings. Please see additional details below:Oppenheimer Fall Healthcare Life Sciences & MedTech SummitDate: Wednesday, September 22ndTime: 1:15 to 1:55 p.m. ETPresenter: Eric Richman, Chief Executive OfficerWebcast: Registration Link – Click...

MBN Corporation Announces Normal Course Issuer Bid

Written by Customer Service on September 17, 2021. Posted in Public Companies.

TORONTO, Sept. 17, 2021 (GLOBE NEWSWIRE) — MBN Corporation announced that it has filed a notice with the Toronto Stock Exchange (the “TSX”) and received its approval to make a normal course issuer bid (“NCIB”) for its equity shares through the facilities of the TSX. This NCIB will commence on September 23, 2021 and will terminate on September 22, 2022. The Fund had 4,068,098 equity shares issued and outstanding as at September 9, 2021. The Fund may, during the 12 month period commencing September 23, 2021 purchase on the TSX up to 294,975 equity shares, being 10% of the public float and may not, in any 30 day period, purchase more than 81,361 equity shares, being 2% of the equity shares issued and outstanding. The Fund will cancel all equity shares purchased pursuant to the bid. As at September 9, 2021 the Fund had purchased 272,100...

Month: September 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals